We help evaluate then develop internal and external product opportunities by:

  • Creating in-depth, scientifically-sound target product profiles and development
    strategies to effectively manage portfolios
  • Conducting in-depth Key Opinion Leader (KOL) interviews
  • Identifying specific go/no-go hurdles to enable informed decisions and establish
    objective criteria for continuing or ending a project
  • Developing successful research and development strategies
  • Producing high-level regulatory documentation and professional publications
  • Strengthening internal and external communication to influence decision makers
    and expedite approvals

At every stage of development from preclinical planning through NDA filing and
marketing, we provide an objective external scientific and commercial perspective.
Providing Expert Support to Biopharmaceutical Executives and Development
Teams Engaged in New Product Planning
 
 
 
This website Copyright 2007 De Young & Hayden, LLC.
The microscopic photograph of penicillin used in the banner is used courtesy of Tina (Weatherby) Carvalho,
MicroAngela.

    "Larry and Brad worked with us on due diligence projects including product evaluation.
    They provided the kind of information we needed to support our internal decision
    making process.  Due to Larry’s & Brad’s scientific, biopharmaceutical and therapeutic
    area expertise, this team required minimum briefing and guidance which allowed us to
    meet challenging project deadlines. Furthermore, we were also impressed with the top-
    level Key Opinion Leaders that they were able to bring to our projects.

    In summary, premium service at very reasonable cost."

    Christian Pangratz
    Director/Program Leader
    NEKTAR THERAPEUTICS
Larry & Brad
conferring with each
other on preparations
for a recent CNS
Scientific Advisory
Board.